This episode features Dr. Michael Weiner, Pediatric Oncologist & Executive Director of Philanthropy for the Dave Cantin Group's DCG GIVING. Here, he discusses current trends in pediatric oncology, his role at DCG, how pediatric oncology has evolved, and more.
Summary
Pediatric Oncologist and Executive Director of Philanthropy, Dr. Michael Weiner, Discusses Current Trends in Pediatric Oncology
Dr. Michael Weiner's Introduction
Dr. Michael Weiner is a pediatric oncologist, who has spent most of his career caring for patients and running clinical trials for children and adolescents afflicted with cancer. Recently, he stepped away from direct patient care to pursue other interests, one of which was to join the Dave Canton Group and lead its new enterprise called DCG Giving.
DCG Giving and Pediatric Cancer Programs
The goal of DCG Giving is to provide much needed financial resources to pediatric cancer programs throughout the country. While cure rates for childhood leukemia, Hodgkin's disease, non-Hodgkin's lymphoma, Wilms tumor, and more are very high, those with brain tumors, sarcomas of bone and soft tissue, and neuroblastomas do not have the same cure rates, and there has not been much progress made in these illnesses in decades.
Innovative Treatment Protocols
Dr. Weiner has worked with an orthopedic surgeon to develop an innovative method of surgery that would spare the limb of a child and not require amputation. He also developed a treatment protocol using three drugs: high dose methotrexate, Cys Platinum, and Adria Mycin, which are still used as main therapy.
Partnering with Children's Oncology Group
Dave Canton Group (DCG) works to fill the void of support for pediatric cancer research from organizations like the National Cancer Institute and American Cancer Society, which provide less than 5% of funds allocated for cancer research. DCG partners with the Children's Oncology Group, giving to the institution in the local area of any acquisition made.
Dr. Weiner's Gratitude
Dr. Weiner is grateful to have been able to participate in fighting pediatric cancer and is humbled by the lives he's been able to save. He discussed current trends in pediatric oncology, his role at DCG, and how pediatric oncology has evolved in his interview on the Becker's Healthcare Podcast.
Conclusion
We appreciate what Dr. Weiner is doing in his career transition and thank him for joining us on the Becker's Healthcare Podcast to share his knowledge.
Note: This is an AI generated transcript, not edited by a staff writer and is solely intended for educational purposes. If you have any questions/concerns, reach out to podcasts@beckershealthcare.com
This episode aired on 10/31/2022 and can be listened here.
Subscribe to Beckers Healthcare Podcast here.